Biomarker Driven Patient Selection Neoadjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to determine if neoadjuvant (treatment before surgery) immunotherapy treatment based on tumor biomarkers results in better participant outcomes. Immunotherapy is the treatment of disease by using a person\'s own immune system.
Epistemonikos ID: c31d83ef470afc71b250e47f1aa270f973f909f7
First added on: May 15, 2024